Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 15.27 -2.61% -0.41
ODT closed down 2.61 percent on Friday, October 19, 2018, on 86 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Oct 29

0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ODT trend table...

Date Alert Name Type % Chg
Oct 19 New 52 Week Closing Low Bearish 0.00%
Oct 19 New Downtrend Bearish 0.00%
Oct 19 Inside Day Range Contraction 0.00%
Oct 19 Wide Bands Range Expansion 0.00%
Oct 19 Down 3 Days in a Row Weakness 0.00%
Oct 19 Oversold Stochastic Weakness 0.00%
Oct 18 New 52 Week Low Weakness -2.61%
Oct 18 Wide Bands Range Expansion -2.61%
Oct 18 Oversold Stochastic Weakness -2.61%
Oct 17 NR7 Range Contraction -4.02%

Older signals for ODT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2018-10-29
Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Is ODT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 17 Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
Oct 1 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $766,400 of Shares
Sep 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $790,000 of Shares
Aug 27 Weekly CEO Buys Highlight
Aug 24 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $146,122 of Shares
Aug 21 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $968,361 of Shares
Aug 20 Report: Exploring Fundamental Drivers Behind Ballard Power, Reading International, Odonate Therapeutics, Stitch Fix, Summit Therapeutics, and Cellectis S.A — New Horizons, Emerging Trends, and Upcoming Developments
Jul 30 Odonate Therapeutics beats by $0.07
Jul 30 Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018
Jun 8 Play the Best Sector of Summer With These ETFs & Stocks
See more ODT news...
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 14.94
Average Volume 60,481
200-Day Moving Average 21.9585
50-Day Moving Average 18.5068
20-Day Moving Average 17.2485
10-Day Moving Average 16.069
Average True Range 1.0397
ADX 25.56
+DI 11.4245
-DI 27.4329
Chandelier Exit (Long, 3 ATRs ) 19.2409
Chandelier Exit (Short, 3 ATRs ) 18.0591
Upper Bollinger Band 19.9133
Lower Bollinger Band 14.5837
Percent B (%b) 0.13
BandWidth 30.898919
MACD Line -0.955
MACD Signal Line -0.8268
MACD Histogram -0.1283
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.00
Resistance 3 (R3) 17.12 16.66 16.71
Resistance 2 (R2) 16.66 16.22 16.60 16.61
Resistance 1 (R1) 15.97 15.95 15.74 15.85 16.52
Pivot Point 15.51 15.51 15.40 15.45 15.51
Support 1 (S1) 14.82 15.07 14.59 14.70 14.02
Support 2 (S2) 14.36 14.80 14.30 13.93
Support 3 (S3) 13.67 14.36 13.83
Support 4 (S4) 13.55